BTM Nanodesign develops protein-based nanomaterials for a diverse set of biotechnological applications. Our material portfolio includes nanomaterials that have a superior antibody binding capacity, compared with alternative products on the market used for antibody purification. In addition, our materials are produced sustainably using only microorganisms. The company is privately owned and located in Uppsala, Sweden. It was founded in 2019 from successful research in protein biotechnology by researchers at the Swedish University of Agricultural Sciences (SLU).